CD8A and head and neck squamous cell carcinoma: We recently reported the presence of HPV-specific CD8+ T cells in the TME of patients with HPV+ HNSCC, demonstrating that a substantial proportion of CD8+ TILs are directed against HPV antigens other than the oncoproteins E6 and E7.